EurekAlert! -
6 Dec 2019 07:00
(Mary Ann Liebert, Inc./Genetic Engineering News) The role of adenosine in neurodegeneration and neuroregeneration has led to growing attention on adenosine receptors as potential drug targets in a range of brain disorders, including neuroregenerative therapy and treatment for amyotrophyic lateral sclerosis (ALS).
Share this Article